Valproate: no benefit for clinical progression in AD


A large, multicentre study in moderate Alzheimer’s disease has found that valproate doesn’t delay the emergence of agitation or psychosis, and doesn’t have a significant effect on cognitive  decline (Tariot et al. Arch Gen Psychiatry 2011; 68: 853-861).

It takes 30 seconds

Recommend to a Colleague

Related Posts

Go back to home page